References

  1. Hughes A and Tonks RS. Experimental embolic carditis. Jn Path & Bact. 1956;72:497-503.   
  2. Davies HTP, Hughes A, Tonks RS. Experimental and clinical lung and heart lesions resulting from intravascular platelet clumping and some factors in their prevention. Proceedings of the 3rd International Pharmacological Meeting, St Paulo, Brazil 1966.  In Drugs in relation to blood coagulation, haemostasis and thromkbosis. Pergamon Press. Ocford and New York 1968. 1971/2 
  3. Elwood PC, Cochrane AL, Burr ML, Sweetnam PM, Williams G, Welsby E, Hughes SJ, Renton R. A randomized controlled trial of acetyl Salicylic Acid in the secondary prevention of mortality from myocardial infarction. Br Med J. 1974;1:436-440.
  4. Dixon B. The top 50: a perspective on the BMJ drawn from the Science Citation Index, 1945-89.. Bernard Dixon. Br.Med.J;1990;301:747-51
  5. Elwood PC, Sweetnam PM. Aspirin and secondary mortality after myocardial infarction.Lancet 1979;1313-15,
  6. Peto R. Editorial: Aspirin after myocardial infarction. Lancet 1980;i:1172-3
  7. International Aspirin Foundation
  8. Sharp DS, Ben-Shlomo Y, Beswick AD. Andrew ME, Elwood PC.  Platelet aggregation in whole blood is a paradoxical predictor of ischaemic stroke: Caerphilly Prospective Study revisited.  Platelets. 2005 Sep;16(6):320-8.
  9. Reuters on 6/14/17 at 5:16 am. http://www.newsweek.com/aspirin-every-day-increases-risk-serious-bleeding-625364
  10. Morgan G. Aspirin for primary prevention of vascular events. Public Health 2009;123:787-8
  11. Elwood PC, Morgan G, Galante J, Chia JWK, Dolwani S, Gaziano JM, Kelson M, Lanas A, Longley M, Phillips CJ, Pickering J, Roberts S, Soon SS, Steward W, Morris D, Weightman AL. Systematic review and meta-analysis of randomised trials to ascertain fatal gastrointestinal bleeding events attributable to preventive low-dose aspirin: No evidence of increased risk, PLOS 2016 http://dx.doi.org/10.1371/journal.pone.0166166
  12. Pierpoint WS. The natural plant product and mammalian tissue. Interdiscip Sci Rev 1997;22:45-52.
  13. Elwood PC, Gallacher AM, Duthie GG Mur LAJ, Morgan G. Aspirin, salicylates and cancer. Lancet 2009; vol 373:9671:1301-9.
  14. Elwood PC. Preserving the benefits of an ‘early’ diagnosis with low-dose aspirin. IN Chatting with the King abut cancer. BMJ 2024. https://www.bmj.com/content/384/bmj.q342/rapid-responses.
  15. Elwood PC, Protty M, Morgan G, Pickering J, Delon C,Watkins J,: Aspirin and cancer: biological mechanisms and clinical outcomes. Royal Society Open Biology September 2022   DOI: 10.1098/rsob.22.0124   https://doi.org/10.1098/rsob.220124
  16. Elwood PC, Morgan G, Delon C, Protty M, Galante J, Pickering J, Watkins J, Weightman A, Morris D. Aspirin and cancer survival: a systematic review and meta-analyses of 118 observational studies of aspirin and 18 cancers. ecancer 2021;15:1258
  17. Elwood PC, Morgan G, Watkins J, Protty M, Mason M, Adams R, Dolwani S, Pickering J, Delon C, Longley M. Aspirin and cancer treatment: systematic reviews and meta-analyses of evidence: for and against.Br J Cancer (2023). https://doi.org/10.1038/s41416-023-02506-5
  18. Elwood PC, Longley M. My health: whose responsibility: A jury decides. J Epidemiol  Community Health 2010;64:761-4.
  19. Sokol DK. Update on the UK law on consent. BMJ. 2015;350:h1481.

References relevant to statements in the Abstract:

Osler W. An account  of certain organisms occurring in the liquor sanguinis. Proc Roy Soc Lond 1874;5:692-734

O’Brien JR. Effects of salicylates on platelet stickiness. Lancet 1968 i:779-81.